Numis Securities rates Alliance Pharma “buy” citing its 44 per cent sales growth and a 200 per cent rise in earnings per share. Says the outlook is strong for 2010.
CABLE & WIRELESS
Collins Stewart is positive on Cable & Wireless saying the prospects for both growth and high dividend yield from the 26 March demerger look attractive.
Evolution Securities upgrades Capgemini to “neutral” with €34 target. Evolution is now convinced on a marginal recovery and says the major 2010 downgrades are now past.